BU BÖLÜM HAKKINDA
Featuring a slide presentation and related discussion from Dr Gilles Salles, including the following topics:
- Recent data with polatuzumab vedotin/bendamustine/rituximab for relapsed/refractory diffuse large B-cell lymphoma (DLBCL) (0:00)
- Available data from trials evaluating tafasitamab/lenalidomide, loncastuximab tesirine and selinexor for DLBCL (12:57)
- Current and future roles of chimeric antigen receptor (CAR) T-cell therapy, bispecific antibodies and combination therapies for DLBCL (21:43)
ingilizce
Amerika Birleşik Devletleri
BU BÖLÜMDE
TRANSKRİPT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
SON BÖLÜMLERİ ARA
Research To Practice | Oncology Videos için geçmiş bölümleri ara.
BU PODCAST'IN DİĞER BÖLÜMLERİ
Featuring perspectives from Dr Shannon N Westin and Dr Stephen "Fred" Divers, moderated by Dr Divers, including the following topics:
Introduction (0:00)
Ovarian Cancer (2:22)
Endometrial Cancer (37:48)
CME information and select publications
Featuring an interview with Dr Alexander E Drilon, including the following topics:
Overview of targetable biomarkers in lung cancer (0:00)
Biomarker testing for genomic alterations in lung cancer (5:24)
Overview of ROS1 alterations in lung cancer (13:44)
Efficacy data with ROS1 inhibitors for…
Featuring perspectives from Dr Samuel J Klempner and Dr Stephen "Fred" Divers, moderated by Dr Divers, including the following topics:
Introduction (0:00)
First-Line Treatment of Metastatic Gastroesophageal Cancer (1:48)
Management of HER2-Positive Gastroesophageal Cancer (25:11)
Neoadjuvant …
Featuring a slide presentation and related discussion from Professor Nicoletta Colombo, including the following topics:
Rationale for targeting the glucocorticoid receptor; relacorilant mechanism of action (0:00)
Key efficacy and safety findings from a Phase II study of relacorilant/nab pacl…
Featuring an interview with Professor Nicoletta Colombo, including the following topics:
Mechanistic effects and rationale underlying the use of relacorilant/nab paclitaxel (0:00)
Rationale underlying the study design of the Phase II BELLA trial and avenues for future exploration (8:31)
Defini…
Feragatname: Bu sayfaya yerleştirilmiş podcast ve sanat eserleri, sahibinin mülkiyetinde olan ve Listen Notes, Inc.'e bağlı olmayan veya tarafından onaylanmayan Dr Neil Love'e aittir.
DÜZENLE
Podcast veritabanını güncel tutmaya yardımcı olduğunuz için teşekkür ederiz.
